Selangor Journal
A bottle of Truvada, the brand name of tenofovir/emtricitabine combination medication used for HIV pre-exposure prophylaxis (PrEP). — Picture by WIKIMEDIA COMMONS

Pilot project on use of PrEP drug to reduce hiv infection — Dr Zaliha

KUALA LUMPUR, Dec 12 — The Health Ministry (MoH) will carry out a pilot project regarding the use of the PrEP (Pre-Exposure Prophylaxis) medicine in several hospitals to assess its effectiveness and safety in reducing the risk of HIV infection.

Health Minister Dr Zaliha Mustafa said the pilot project was necessary before the drug is certified by the ministry for public consumption.

“Its use has been studied. We have discussed with religious experts to understand from a legal point of view and so on and if we look at its use, it is not only for the LGBT group (lesbian, gay, bisexual and transgender) but there are several other groups that will use it for better results so that we can prevent the spread of HIV,” she said.

Dr Zaliha told reporters this after the launch ceremony of the Serdang Hospital Heart Centre operations here today.

The use of PrEP medication is said to be able to reduce the risk of contracting HIV from sex by about 90 per cent when taken according to prescription.

On the issue of the alleged misappropriation of the Covid-19 management fund, estimated at RM530 billion, she said discussions on the matter will be held at the ministry level soon.

Last Friday, the Malaysian Anti-Corruption Commission (MACC) said preliminary investigations show that alleged irregularities in the management of Covid-19 funds involved allocations estimated at RM530 billion.

Of the amount, RM92.5 billion involved government funds whereas RM437.5 billion was not from the government, the MACC said.

— Bernama

Top Picks

Asean countries discuss plans for financial cooperation

Editor Selangor Journal

Para cycling squad sweep two gold, two silver in India 

Editor Selangor Journal

Malaysia, Japan strengthen halal trade and investment  

Editor Selangor Journal